amiodarone has been researched along with Goiter, Nodular in 11 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Goiter, Nodular: An enlarged THYROID GLAND containing multiple nodules (THYROID NODULE), usually resulting from recurrent thyroid HYPERPLASIA and involution over many years to produce the irregular enlargement. Multinodular goiters may be nontoxic or may induce THYROTOXICOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amiodarone-induced thyrotoxicosis (AIT) develops in 3% of amiodarone-treated patients in North America." | 8.85 | Amiodarone-induced thyrotoxicosis: a review. ( Houlden, RL; Tsang, W, 2009) |
| "To report a case of amiodarone-induced thyrotoxicosis (AIT) concomitant with thyroid cancer in multinodular goiter (MNG)." | 7.78 | Amiodarone-induced thyrotoxicosis with thyroid papillary cancer in multinodular goiter: case report. ( Akamizu, T; Inaba, H; Kobayashi, S; Komatsu, M; Suzuki, S; Takeda, T, 2012) |
| "A 64-year-old female with atrial fibrillation and nodular goiter progressed to overt thyrotoxicosis after receiving therapy with amiodarone 200 mg/day for less than 12 weeks." | 7.75 | Amiodarone-induced thyrotoxicosis in a patient with autonomously functioning nodular goiter. ( Hsiao, SH; Huang, SM; Hung, HC; Liang, YL; Ou, HY; Peng, SL; Wu, TJ, 2009) |
| "Amiodarone-induced thyrotoxicosis is a life-threatening condition." | 7.74 | Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study. ( Ambrosini, CE; Berti, P; Bogazzi, F; Martino, E; Materazzi, G; Miccoli, P, 2007) |
| "Amiodarone-induced thyrotoxicosis (AIT) may be caused by excessive thyroidal hormone synthesis and release (type 1) or by a destructive process (type 2)." | 7.74 | Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. ( Cianchetti, ME; Loy, M; Mariotti, S; Melis, A; Perra, E; Piga, M; Pinna, G; Serra, A, 2007) |
| "Amiodarone-induced thyrotoxicosis (AIT) is a challenging management problem, since patients treated with amiodarone invariably have underlying heart disease." | 7.73 | Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality. ( Diamond, T; Lewis, M; O'Sullivan, AJ, 2006) |
| "Amiodarone-induced thyrotoxicosis (AIT) occurs both in abnormal thyroid glands (nodular goiter, latent Graves' disease) (type I AIT) or in apparently normal thyroid glands (type II AIT)." | 7.69 | Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. ( Bartalena, L; Bartolozzi, C; Bogazzi, F; Brogioni, S; Burelli, A; Martino, E; Mazzeo, S; Vitti, P, 1997) |
| "Iodine-induced hyperthyroidism has been frequently described when iodine is introduced into an iodine-deficient area." | 7.67 | Five patients with iodine-induced hyperthyroidism. ( Braverman, LE; Mordes, JP; Rajatanavin, R; Safran, M; Stoller, WA, 1984) |
| "The off-label use of OCAs was reviewed for the management of neonatal and adult Graves' disease, subacute thyroiditis, amiodarone-induced thyroiditis (AIT), exogenous hyperthyroidism, toxic multinodular goiter (TMNG), thyrotropinoma, thyrotoxicosis during pregnancy, rapid pre-operative control of hyperthyroidism, and thyroid storm." | 4.90 | Review of oral cholecystographic agents for the management of hyperthyroidism. ( Kim, TY; Martinez, DS; Tyer, NM, 2014) |
| "Amiodarone-induced thyrotoxicosis (AIT) develops in 3% of amiodarone-treated patients in North America." | 4.85 | Amiodarone-induced thyrotoxicosis: a review. ( Houlden, RL; Tsang, W, 2009) |
| "To report a case of amiodarone-induced thyrotoxicosis (AIT) concomitant with thyroid cancer in multinodular goiter (MNG)." | 3.78 | Amiodarone-induced thyrotoxicosis with thyroid papillary cancer in multinodular goiter: case report. ( Akamizu, T; Inaba, H; Kobayashi, S; Komatsu, M; Suzuki, S; Takeda, T, 2012) |
| "A 64-year-old female with atrial fibrillation and nodular goiter progressed to overt thyrotoxicosis after receiving therapy with amiodarone 200 mg/day for less than 12 weeks." | 3.75 | Amiodarone-induced thyrotoxicosis in a patient with autonomously functioning nodular goiter. ( Hsiao, SH; Huang, SM; Hung, HC; Liang, YL; Ou, HY; Peng, SL; Wu, TJ, 2009) |
| "Amiodarone-induced thyrotoxicosis is a life-threatening condition." | 3.74 | Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study. ( Ambrosini, CE; Berti, P; Bogazzi, F; Martino, E; Materazzi, G; Miccoli, P, 2007) |
| "Amiodarone-induced thyrotoxicosis (AIT) may be caused by excessive thyroidal hormone synthesis and release (type 1) or by a destructive process (type 2)." | 3.74 | Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. ( Cianchetti, ME; Loy, M; Mariotti, S; Melis, A; Perra, E; Piga, M; Pinna, G; Serra, A, 2007) |
| "Amiodarone-induced thyrotoxicosis (AIT) is a challenging management problem, since patients treated with amiodarone invariably have underlying heart disease." | 3.73 | Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality. ( Diamond, T; Lewis, M; O'Sullivan, AJ, 2006) |
| "Amiodarone-induced thyrotoxicosis (AIT) occurs both in abnormal thyroid glands (nodular goiter, latent Graves' disease) (type I AIT) or in apparently normal thyroid glands (type II AIT)." | 3.69 | Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. ( Bartalena, L; Bartolozzi, C; Bogazzi, F; Brogioni, S; Burelli, A; Martino, E; Mazzeo, S; Vitti, P, 1997) |
| "Iodine-induced hyperthyroidism has been frequently described when iodine is introduced into an iodine-deficient area." | 3.67 | Five patients with iodine-induced hyperthyroidism. ( Braverman, LE; Mordes, JP; Rajatanavin, R; Safran, M; Stoller, WA, 1984) |
| "Thyrotoxicosis is a common disorder, especially in women." | 2.48 | Thyrotoxicosis. ( Boelaert, K; Franklyn, JA, 2012) |
| "Thyrotoxicosis is a well defined clinical entity, determined by an increase of plasma levels of thyroid hormones (T3 and T4)." | 2.41 | [The management of thyrotoxicosis: a schematic approach]. ( Carapezzi, C; Corsello, SM; Papi, G, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tyer, NM | 1 |
| Kim, TY | 1 |
| Martinez, DS | 1 |
| Liang, YL | 1 |
| Huang, SM | 1 |
| Peng, SL | 1 |
| Hsiao, SH | 1 |
| Hung, HC | 1 |
| Ou, HY | 1 |
| Wu, TJ | 1 |
| Tsang, W | 1 |
| Houlden, RL | 1 |
| Inaba, H | 1 |
| Suzuki, S | 1 |
| Takeda, T | 1 |
| Kobayashi, S | 1 |
| Akamizu, T | 1 |
| Komatsu, M | 1 |
| Franklyn, JA | 1 |
| Boelaert, K | 1 |
| O'Sullivan, AJ | 1 |
| Lewis, M | 1 |
| Diamond, T | 1 |
| Berti, P | 1 |
| Materazzi, G | 1 |
| Bogazzi, F | 2 |
| Ambrosini, CE | 1 |
| Martino, E | 2 |
| Miccoli, P | 1 |
| Loy, M | 1 |
| Perra, E | 1 |
| Melis, A | 1 |
| Cianchetti, ME | 1 |
| Piga, M | 1 |
| Serra, A | 1 |
| Pinna, G | 1 |
| Mariotti, S | 1 |
| Rajatanavin, R | 1 |
| Safran, M | 1 |
| Stoller, WA | 1 |
| Mordes, JP | 1 |
| Braverman, LE | 1 |
| Bartalena, L | 1 |
| Brogioni, S | 1 |
| Mazzeo, S | 1 |
| Vitti, P | 1 |
| Burelli, A | 1 |
| Bartolozzi, C | 1 |
| Papi, G | 1 |
| Carapezzi, C | 1 |
| Corsello, SM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Open-label, Parallel-group Study to Explore the Efficacy of High-intensity Focused Ultrasound (HIFU) Versus Fixed-dose Radioiodine-131 in the Treatment of Relapsed Graves' Disease[NCT03013257] | 240 participants (Actual) | Interventional | 2017-04-25 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for amiodarone and Goiter, Nodular
| Article | Year |
|---|---|
Review of oral cholecystographic agents for the management of hyperthyroidism.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Female; Goiter, Nodular; Humans; Hyperthyroidism; Neoplas | 2014 |
Amiodarone-induced thyrotoxicosis: a review.
Topics: Amiodarone; Anti-Arrhythmia Agents; Goiter, Nodular; Graves Disease; Humans; Thyroiditis, Subacute; | 2009 |
Thyrotoxicosis.
Topics: Agranulocytosis; Amiodarone; Antithyroid Agents; Atrial Fibrillation; Autoimmune Diseases; Child; Ex | 2012 |
[The management of thyrotoxicosis: a schematic approach].
Topics: Adenoma; Adrenal Cortex Hormones; Adult; Aged; Amiodarone; Antithyroid Agents; Cardiovascular Diseas | 2002 |
7 other studies available for amiodarone and Goiter, Nodular
| Article | Year |
|---|---|
Amiodarone-induced thyrotoxicosis in a patient with autonomously functioning nodular goiter.
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Goiter, Nodular; Humans; Middle Aged; Thyrotoxicosis | 2009 |
Amiodarone-induced thyrotoxicosis with thyroid papillary cancer in multinodular goiter: case report.
Topics: Amiodarone; Anti-Arrhythmia Agents; Carcinoma; Carcinoma, Papillary; Goiter, Nodular; Humans; Male; | 2012 |
Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Goiter, Nodular; Graves Disease; Humans; Male | 2006 |
Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study.
Topics: Aged; Amiodarone; Anesthesia, Local; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Autonomic Nerve B | 2007 |
Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Female; Goiter, Nodular; Graves D | 2007 |
Five patients with iodine-induced hyperthyroidism.
Topics: Adult; Amiodarone; Chlorobutanol; Coloring Agents; Coronary Artery Bypass; Drug Combinations; Female | 1984 |
Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis.
Topics: Adult; Aged; Amiodarone; Antithyroid Agents; Diagnosis, Differential; Female; Glucocorticoids; Goite | 1997 |